Hematology/Oncology

Top Story

Autologous, nonmyeloablative HSCT show promise for advanced multiple myeloma

February 11, 2016

A frontline transplant tandem approach consisting of autologous and nonmyeloablative allogeneic transplantation demonstrated promising OS and PFS among patients with multiple myeloma, according to phase 2 study results.

Although new drug therapies and autologous hematopoietic stem cell transplantation have improved outcomes for multiple myeloma, the condition remains largely incurable, according to study background.

In the Journals

Caplacizumab induces rapid response for acquired TTP

February 10, 2016
Caplacizumab induced a faster response time than placebo among patients with acquired thrombotic thrombocytopenic purpura, a rare blood-clotting disorder, according to…
Video

VIDEO: Physicians have ‘3 main opportunities’ to reduce colorectal cancer in younger patients

February 10, 2016
As the prevalence of colorectal cancer rises “slowly and steadily” among patients under the age of 50 years, clinicians have three major opportunities to…

Hereditary cancer foundation launches Lynch Syndrome patient registry

February 10, 2016
AliveAndKickn has announced the launch of the HEROIC Registry, a genetic database for people with Lynch Syndrome to share data and further research, according to a press…
In the Journals

Obesity linked to poor outcomes in acute promyelocytic leukemia

February 10, 2016
Obesity appeared significantly associated with shorter DFS and OS among adult patients with acute promyelocytic leukemia, according to a pooled analysis of four clinical…
More News Headlines »
CME

Optimizing the Management of Metastatic Melanoma: Clinical Insights for Selecting First-line Therapy

This activity is supported by an independent educational grant from Merck & Co., Inc.

The incidence of melanoma is continuing to increase worldwide. In recent years, the treatment landscape for this…
More »
Meeting News CoverageVideo

VIDEO: Novel prediction model accurately determines survival in gastric cancer

February 5, 2016
More »
Featured
CME

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan